QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 期刊论文 CANCER RESEARCH, 2018, 卷号: 78, 期号: 4 作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Use of trastuzumab as an adjuvant/neoadjuvant therapy in patients with HER2-positive breast cancer in China: The Nvwa study 期刊论文 MEDICINE, 2018, 卷号: 97, 期号: 21 作者:  Li, Junjie;  Shao, Zhimin;  Xu, Binghe;  Jiang, Zefei;  Cui, Shude 收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05 adjuvant therapy  breast cancer  HER2-targeted therapy  neoadjuvant therapy  trastuzumab   Treatment patterns for adjuvant docetaxel-based chemotherapy in early-stage breast cancer in China: A pooled retrospective analysis of four observational studies 期刊论文 CHINESE JOURNAL OF CANCER RESEARCH, 2018, 卷号: 30, 期号: 3 作者:  Xu, Binghe;  Shao, Zhimin;  Wang, Shui;  Jiang, Zefei;  Hu, Xichun 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05 Adjuvant chemotherapy  docetaxel  early-stage breast cancer   A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文 作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 Treatment patterns for adjuvant docetaxel-based chemotherapy in early-stage breast cancer in China: A pooled retrospective analysis of four observational studies 期刊论文 2018, 卷号: 30, 期号: 3, 页码: 327-+ 作者:  Xu, Binghe;  Shao, Zhimin;  Wang, Shui;  Jiang, Zefei;  Hu, Xichun 收藏  |  浏览/下载：11/0  |  提交时间：2020/01/03 Adjuvant chemotherapy  docetaxel  early-stage breast cancer   A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文 CANCER RESEARCH, 2018-02-01 作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei 收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03 A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 期刊论文 2018, 卷号: 78, 期号: 4 作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei 收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03